A Rockville immunotherapy company struck an $8 million deal to take back ownership of the drug candidates it’s been licensing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback